Macular Degeneration Trial, Recruiting NCT01866371 Sponsor: University of Pennsylvania Condition: Macular Degeneration
Back to Macular Degeneration

Macular Degeneration Trial, Recruiting

NCT01866371
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 7 years or older, either male or female.
  • Children aged 7 to 17 years old must give their own agreement (assent) to take part, and a parent or guardian must also give their permission.
  • People who are willing and able to follow the imaging procedures as assessed by the study team.

Who may not be able to join:

  • People who are at risk of sudden-onset glaucoma (a condition involving increased pressure in the eye).
  • People who are sensitive to light and have strong negative psychological reactions to flashes of light.
  • People with certain eye conditions such as cloudiness in the eye, a very high level of vision correction needed, or frequent uncontrolled eye movements — as determined by the study team (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jessica IW Morgan, PhD, University of Pennsylvania

Phone: 215-614-4196

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2013
Est. completion
1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

high-resolution images of retina

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov